Moody Aldrich Partners LLC Purchases 21,983 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Moody Aldrich Partners LLC raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 47.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,880 shares of the company's stock after purchasing an additional 21,983 shares during the quarter. HealthEquity makes up 1.3% of Moody Aldrich Partners LLC's holdings, making the stock its 22nd biggest position. Moody Aldrich Partners LLC owned about 0.08% of HealthEquity worth $5,999,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Proficio Capital Partners LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $39,000. Smartleaf Asset Management LLC increased its position in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the period. Jones Financial Companies Lllp increased its position in shares of HealthEquity by 1,112.3% in the fourth quarter. Jones Financial Companies Lllp now owns 1,285 shares of the company's stock worth $123,000 after purchasing an additional 1,179 shares during the period. State of Michigan Retirement System increased its position in shares of HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after purchasing an additional 100 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in shares of HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock worth $104,280,000 after purchasing an additional 25,004 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Down 0.3%

NASDAQ HQY traded down $0.33 on Monday, hitting $101.83. 877,726 shares of the company were exchanged, compared to its average volume of 863,019. The company has a market cap of $8.81 billion, a PE ratio of 74.33, a PEG ratio of 1.57 and a beta of 0.49. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $116.65. The stock has a fifty day moving average of $99.74 and a 200-day moving average of $98.31. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The firm had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. During the same period last year, the firm earned $0.80 earnings per share. As a group, analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director directly owned 84,969 shares of the company's stock, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the transaction, the director directly owned 253,510 shares in the company, valued at $28,413,400.80. The trade was a 34.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 295,700 shares of company stock valued at $32,968,990. Corporate insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. KeyCorp decreased their price target on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. Bank of America lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Royal Bank Of Canada lifted their target price on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research report on Wednesday, June 4th. JMP Securities boosted their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Finally, Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $118.09.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.